Immunome, Inc. (IMNM) is a publicly traded Healthcare sector company. As of September 2, 2026, IMNM trades at $27.07 with a market cap of $3.11B and a P/E ratio of -11.07. IMNM moved +0.02% today. Year to date, IMNM is +30.00%; over the trailing twelve months it is +191.65%. Its 52-week range spans $5.15 to $30.06. Analyst consensus is strong buy with an average price target of $36.30. Rallies surfaces IMNM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Immunome, Inc. (IMNM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IMNM moved +0.02% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $27.07 |
| Market Cap | $3.11B |
| P/E Ratio | -11.07 |
| EPS | $-2.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.06 |
| 52-Week Low | $5.15 |
| Volume | 50 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.94M |
| Net Income | $-212.39M |
| Gross Margin | 0.00% |
12 analysts cover IMNM: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $36.30.